Second Lancet Commission on adolescent health records some gains; indicates need for more investments, laws to ensure wellbeing
The second Lancet Commission on adolescent health and wellbeing has recorded that despite progress in some areas, without increasing investments, by the end of 2030, at least half of the world's adolescents (1 billion people) will be living in multi-burden countries where adolescents experience a complex and excess burden of disease. Further it has projected that in 2030, 464 million adolescents globally will be overweight or obese (143 million more than in 2015) and 42 million years of health life will be lost to mental disorders or suicide (2 million more than in 2015).
The report at the end of the Commission's term released this week, pointed out that funding for adolescent health and wellbeing is not commensurate with the magnitude of the challenge and is not targeted to the areas of greatest need. For example, specific funding for adolescent health accounted for only 2·4% of total development assistance for health in 2016–21, despite adolescents accounting for 25·2% of the world population.
Diverse group of commissioners
Initiated in 2021, the Commission brought together a diverse group of 44 commissioners, including 10 youth. The deliberations have been shaped by meaningful engagement with adolescents and youth throughout all aspects, including bringing in 122 adolescents to be part of Youth Solution Labs.
World Health Organization (WHO) Director General Adhanom Ghebreysus Tedros, writing in The Lancet, said: 'The second Lancet Commission on adolescent health and wellbeing shows that significant strides have been made in improving adolescent health globally, while laying out significant challenges ahead. Over the past two decades, adolescent mortality has declined by 27%, owing to substantial reductions in malnutrition and communicable diseases, and expanded access to education—especially for girls. These changes will pave the way towards greater gender equity and better life outcomes.'
Why is this report significant?
Sheer numbers, for one. The global population of roughly 2 billion adolescents constitutes around 24% of the world's population. 'The current generation of adolescents is the largest in the history of humanity...Projections suggest that by 2100 around 46% of the world's adolescents will live in Africa, and that 85% will live in Africa or Asia,' the report states. The proportion of adolescents living in conflict-affected areas has more than doubled since the 1990s. An estimated 340 million (18%) adolescents now live in conflict-affected areas.
Better indicators and improvement in data systems at the national and global level are required to monitor systemic changes in health and wellbeing outcomes and in the circumstances in which adolescents are growing up, the report added. As Dr. Tedros said: 'Data matter, too. That is why WHO, together with partners, launched Global Action for the Measurement of Adolescent Health to close critical data gaps and strengthen accountability—including in underexplored domains such as adolescent connectedness.'
Social media impact
Interestingly, the report draws attention to the possible impact of social media on the lives of adolescents who it calls the 'first global generation of digital natives'. Globally, 79% of 15–24-year-olds use the internet, a much higher proportion than among any other age-group, and more than 95% of adolescents in high-income and upper-middle-income countries are digitally connected. It calls for 'enabling laws and policies provide the foundational environments for sustained improvements in adolescent health and wellbeing. These environments should protect adolescent sexual and reproductive health and rights, reduce the impact of the commercial determinants of health, and promote the healthy use of social media and online spaces.'
The report has also asked for multisectoral actions on mental health, nutrition, sexual and reproductive health, and violence to amplify gains made in adolescent health. Coordination is needed between ministries of health and of education with regard to interventions in schools.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
an hour ago
- NDTV
WHO Is Finalising A New Treaty To Prep For The Next Pandemic, But US Isn't Signing
On March 20, 2025, members of the World Health Organization adopted the world's first pandemic agreement, following three years of 'intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.' The U.S., however, did not participate, in part because of its intention to withdraw from the WHO. Global health experts are hailing the agreement as a historic moment. What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic? The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.'s absence from it. What will the pandemic agreement do? The accord will bolster pandemic preparation within individual countries and around the world. Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts. It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly. The agreement will take effect once enough countries ratify it, which may take several years. Why isn't the US involved? The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations. Prior to Donald Trump's reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank's concerns about U.S. sovereignty. The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term. Why could the lack of US involvement be beneficial for the world? The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions. It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry's profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures. Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies. While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines. How could the agreement broaden access for treatments? One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed. Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world. The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries. If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives. What more should be done, and does the US have a role to play? In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID. Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics. It will also be imperative for member countries to provide funding to support the agreement's goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people's arms.
Hans India
5 hours ago
- Hans India
AB-PMJAY, Jan Aushadhi Kendras boosting healthcare for middle class in last 11 years
New Delhi: Flagship scheme like the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and the Jan Aushadhi Kendras under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has significantly enhanced healthcare for middle class in the last 11 years, according to an official statement issued on Thursday. 'Healthcare in India has seen a quiet but far-reaching shift in the last eleven years. Through a blend of targeted public schemes and digital reach, the Government has made quality healthcare both affordable and accessible for millions, especially the middle class,' the statement said. With more than 41.02 crore Ayushman Cards created in 33 States and Union Territories, as of May 30, AB-PMJAY has emerged as one of the world's largest publicly funded health assurance schemes. The scheme has enabled 8.59 crore hospital admissions worth Rs 1,19,858 crore, ensuring access to secondary and tertiary care without pushing families into debt, the statement said. Further, with the number of Jan Aushadhi Kendras rising to 16,469, as of May 30, from just 80 in 2014, the PMBJP brought essential medicines within reach of the common citizen. These outlets offer medicines that cost 50 to 80 per cent less than branded options, with strict quality standards ensured through WHO-GMP certified suppliers. The scheme serves around 10 to 12 lakh people daily, and cumulative savings over the last eleven years are estimated to be more than Rs 38,000 crore, the statement said. The product range now includes 2,110 medicines, including for chronic conditions like diabetes or heart disease, and 315 surgical products, covering all major treatments, cutting down financial stress for millions of families, especially the middle class. 'From free hospitalisation for senior citizens to low-cost medicines available nationwide, people today have better control over their health expenses. The digital backbone supporting these schemes has made enrolment, access, and tracking easier than ever. This change has allowed the middle class to benefit from savings on medicines, timely treatment, and greater medical security without bureaucratic hassles,' the statement said. 'Over the past eleven years, the government has shown unwavering commitment to uplifting the middle class in meaningful ways. The policies and reforms introduced have not only eased everyday challenges but also strengthened financial security, housing, healthcare, and skill development,' it added.
The Hindu
5 hours ago
- The Hindu
All you need to know about: Alzheimer's disease
The deaths of actor Gene Hackman and his wife Betsy Arakawa made headlines some months ago after their bodies were found at their home in Santa Fe, United States. While Ms. Arakawa was found to have died of hantavirus pulmonary syndrome, a rare rodent-borne disease, Mr. Hackman's autopsy findings indicated severe heart disease as well as advanced stages of Alzheimer's disease. The actor was 95 at the time of his death. What is Alzheimer's disease and what do you need to know about it? Read on, to find out. What is Alzheimer's disease? Alzheimer's disease is the most common form of dementia, which is an umbrella term for several diseases that affect the brain, impairing memory, thinking, reasoning, affecting a person's ability to function well. Dementia is not a normal part of ageing. Alzheimer's disease, the World Health Organization (WHO) states, may contribute to 60–70% of dementia cases. Dementia is currently the seventh-leading cause of death and one of the major causes of disability and dependency among older people globally. India is expected to have about 7.6 million afflicted by 2030, as per the Dementia in India Report, 2020, majority of whom are likely to be diagnosed with Alzheimer's. Alzheimer's is a progressive, neurodegenerative disease, which means that over time, brain cells are damaged and die, leading the brain to shrink. What causes Alzheimer's disease? The exact causes that lead to Alzheimer's disease are still being studied and are not fully understood. Scientists believe the disease may be caused by the abnormal build-up of proteins in the brain. The brain is made up of billions of nerve cells or neurons that are connected in networks. When a protein called beta amyloid builds up and clumps together, it forms plaques that affect the communication between neurons. Another protein, the tau protein, becomes twisted into strands called tangles, which also affect the functioning of the cells, and damages them. When the cells become damaged and lose their connections with each other, they eventually die. The destruction and death of the brain nerve cells cause the symptoms of Alzheimer's. Genetics, environmental and environmental factors are believed to contribute to the cause. Who is at risk for Alzheimer's disease? Age, being 65 years or older, is one of the primary risk factors. Other risk factors include a family history of Alzheimer's, smoking, a traumatic head injury, untreated depression as well as lifestyle conditions associated with heart disease such as obesity, high blood pressure and high blood sugar. The WHO also lists drinking too much alcohol, being physically inactive and being socially isolated as risk factors for dementia. What are the signs and symptoms? One of the first and most common symptoms may be memory loss -- difficulty in remembering recent events or conversations and newly-learned information. This is not the occasional bout of forgetting that most of us may experience -- this form of memory loss is lasting. It may lead, over time, to patients having trouble finding the right words, asking questions over and over, putting familiar objects in unfamiliar places, getting lost in a previously well-known locations and forgetting faces and names. Other symptoms involve thinking and reasoning abilities as well as changes in speech, moods, personality and behaviour. These can include: confusion, difficulties in paying bills and managing finances, difficulties in day-to-day activities such as cooking or driving and poor judgement. Personality changes can include suspicion of others, mood swings, hallucinations, anxiety, depression, social withdrawal and anger or aggression. What is the prognosis? The rate of progression for Alzheimer's disease varies. In the later stages of the disease, a person may lose physical abilities, may need help with all activities, and may lost the ability to communicate. Some people may live several years after a diagnosis, while others may live for fewer years. The stage of the disease at the time of diagnosis and other factors of health may affect life expectancy. How is it treated? It is important to see a doctor if you are concerned about memory or other thinking skills or if you have these concerns about a family member. At present, there is no cure for Alzheimer's., however treatment can help manage symptoms and treat the progression of the disease. Early treatment is optimal to help preserve brain health. Medicines may be prescribed where necessary. This apart, medication may also be given for symptoms such as depression, hallucinations, agitation and mood changes. Opting for a healthy lifestyle including adequate exercise, well-balanced, nutritious meals, keeping up with hobbies and social activities, may all help. Creating a supportive and caring environment at home, one that is calm, structured, is also important to help improve well-being and the ability to function.
